Exactly why simply waiting for some sort of efficacy data is a poor way to manage a company. It is a complete gamble, red or black on the roulette wheel.
What if all four measures show results but the viral load is only reduced by 70% with the highest does? That is a measure of efficacy but it is one that is unlikely to generate interest from a partner.
We all hope TT-034 works and works well. All that I am doing is pointing out the risks with the present situation.
- Forums
- ASX - By Stock
- Fair value
Exactly why simply waiting for some sort of efficacy data is a...
-
Share
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne